3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
52
Brain Neoplasms
50
Carcinoma, Non-Small-Cell Lung
48
Neoplasm Metastasis
29
Lung Neoplasms
29
Breast Neoplasms
23
Pancreatic Neoplasms
16
Melanoma
15
Carcinoma, Renal Cell
14
Carcinoma, Hepatocellular
13
Neoplasms
9
Squamous Cell Carcinoma of Head and Neck
8
Urinary Bladder Neoplasms
7
Small Cell Lung Carcinoma
7
Colorectal Neoplasms
7
Kidney Neoplasms
5
Liver Neoplasms
4
Glioblastoma
4
Uveal Melanoma
3
Triple Negative Breast Neoplasms
3
Spinal Cord Neoplasms
3
Sarcoma
3
Prostate Cancer Metastatic
3
NSCLC
3
Meningioma
3
Hematologic Neoplasms
3
Head and Neck Neoplasms
3
Gastrointestinal Neoplasms
3
Carcinoma, Transitional Cell
3
Adenocarcinoma
3
Interventions
Cisplatin
5
pembrolizumab
4
Surveys and Questionnaires
2
Radiotherapy
2
N-benzhydryl-5-(2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo(1,2-a)(1,5)diazocine-8-carboxamide
2
Fluorouracil
2
Docetaxel
2
Cetuximab
2
niraparib
1
monalizumab
1
durvalumab
1
dostarlimab
1
Tablets
1
Surgical Flaps
1
Radiotherapy, Intensity-Modulated
1
Radiation
1
LY2940680
1
Interviews as Topic
1
Combined Modality Therapy
1
Chemical Fractionation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Laryngeal Diseases
×
Radiosurgery
×
1 year
×
Clear all
No trials found.